Rapid and simultaneous detection of the chlorhexidine and mupirocin resistance genes qacA/B and mupA in clinical isolates of methicillin-resistant Staphylococcus aureus

Diagnostic Microbiology and Infectious Disease

Volumn 77, Issue 3, 2013, Pages 270-272

  Gann, Patrick Mc ^a   Milillo, Michael ^a   Kwak, Yoon I ^a   Quintero, Reyes ^a   Waterman, Paige E ^a   Lesho, Emil ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Chlorhexidine; MRSA; MupA; Mupirocin; QacA

Indexed keywords

CHLORHEXIDINE; PSEUDOMONIC ACID;

ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL SURVIVAL; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUPA GENE; NONHUMAN; PRIORITY JOURNAL; QACA GENE; QACB GENE; REAL TIME POLYMERASE CHAIN REACTION;

CHLORHEXIDINE; MRSA; MUPA; MUPIROCIN; QACA;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CHLORHEXIDINE; DRUG RESISTANCE, BACTERIAL; HUMANS; MEMBRANE TRANSPORT PROTEINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MUPIROCIN; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL INFECTIONS; TIME FACTORS;

EID: 84885370908     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.06.006     Document Type: Article

References (21)

1. Antonio M., McFerran N., Pallen M.J. Mutations affecting the Rossman fold of isoleucyl-tRNA synthetase are correlated with low-level mupirocin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2002, 46:438-442.
2. Batra R., Cooper B.S., Whiteley C., Patel A.K., Wyncoll D., Edgeworth J.D. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010, 50:210-217.
3. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009, 55:611-622.
4. Cadilla A., David M.Z., Daum R.S., Boyle-Vavra S. Association of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the midwestern United States. J Clin Microbiol 2011, 49:95-100.
5. Clifford R.J., Milillo M., Prestwood J., Quintero R., Zurawski D.V., Kwak Y.I., et al. Detection of bacterial 16S rRNA and identification of four clinically important bacteria by real-time PCR. PLoS One 2012, 7:e48558.
6. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 22nd Informational Supplement (M100-S22). Wayne, PA: CLSI; 2012.
7. DeMarco C.E., Cushing L.A., Frempong-Manso E., Seo S.M., Jaravaza T.A., Kaatz G.W. Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob Agents Chemother 2007, 51:3235-3239.
8. Deshpande L.M., Fix A.M., Pfaller M.A., Jones R.N. Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods. Diagn Microbiol Infect Dis 2002, 42:283-290. Group, SASPP.
9. Driscoll D.G., Young C.L., Ochsner U.A. Transient loss of high-level mupirocin resistance in Staphylococcus aureus due to MupA polymorphism. Antimicrob Agents Chemother 2007, 51:2247-2248.
10. Eltringham I. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 1997, 35:1-8.
11. Hurdle J.G., O'Neill A.J., Mody L., Chopra I., Bradley S.F. In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant !Staphylococcus aureus associated with failure of mupirocin prophylaxis. J Antimicrob Chemother 2005, 56:1166-1168.
12. Lee A.S., Macedo-Vinas M., François P., Renzi G., Schrenzel J., Vernaz N., Pittet D., et al. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis 2011, 52(12):1422-1430.
13. McDanel J.S., Murphy C.R., Diekema D.J., Quan V., Kim D.S., Peterson E.M., et al. Chlorhexidine and mupirocin susceptibilities of methicillin-resistant Staphylococcus aureus from colonized nursing home residents. Antimicrob Agents Chemother 2013, 57:552-558.
14. McDougal L.K., Fosheim G.E., Nicholson A., Bulens S.N., Limbago B.M., Shearer J.E., et al. Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States. Antimicrob Agents Chemother 2010, 54:3804-3811.
15. McGann P., Kwak Y.I., Summers A., Cummings J.F., Waterman P.E., Lesho E.P. Detection of qacA/B in clinical isolates of methicillin-resistant Staphylococcus aureus from a regional healthcare network in the eastern United States. Infect Control Hosp Epidemiol 2011, 32:1116-1119.
16. Perez-Fontan M., Rosales M., Rodriguez-Carmona A., Falcon T.G., Valdes F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002, 39:337-341.
17. Rahman M., Noble W.C., Cookson B.D. Mupirocin-resistant Staphylococcus aureus. Lancet 1987, 2:1472-1473.
18. Shore A.C., Deasy E.C., Slickers P., Brennan G., O'Connell B., Monecke S., et al. Detection of staphylococcal cassette chromosome mec type XI carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal complex 130 methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2011, 55:3765-3773.
19. Simor A.E. Staphylococcal decolonisation: an effective strategy for prevention of infection?. Lancet Infect Dis 2011, 11:952-962.
20. Smith K., Gemmell C.G., Hunter I.S. The association between biocide tolerance and the presence or absence of qac genes among hospital-acquired and community-acquired MRSA isolates. J Antimicrob Chemother 2008, 61:78-84.
21. Walker E.S., Vasquez J.E., Dula R., Bullock H., Sarubbi F.A. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective?. Infect Control Hosp Epidemiol 2003, 24:342-346.